Uric Acid Plays a Key Role in Hypertension and its Long-term Risk

Authors

  • Yue Wang
  • Ziyou Li

DOI:

https://doi.org/10.54097/9hcmxc60

Keywords:

Uric acid; hypertension; Mendelian randomization study; Meta-Analysis, mechanism.

Abstract

Hypertension is a chronic disease now prevalent in modern societies and is a separate heart failure threat. If leave unattended a lengthy amount duration, it may lead to long-term risks such as stroke or heart attack, kidney damage, osteoporosis, and even death. Human metabolism of purines results in uric acid, which may have a significant impact on the onset and subsequent risk of pressure. The connection that exists among uric acid and hypertension was found to be progressively observable in Mendelian randomization studies, but no further strong subsequent studies have been conducted as of 2021 to illustrate the relationship. Meta-analysis studies have shown a potential link between elevated uric acid levels and an increased risk of hypertension, However, there is still a need to investigate the potential benefits of uric acid-lowering medications in reducing the risk of hypertension. Previous studies involving large sample sizes have indicated a positive association between uric acid levels and the likelihood of developing hypertension, but there is some geographic variation in the studies and the conclusions are limited and difficult to generalize. Multiple studies have given possible mechanisms at the mechanistic level for uric acid triggering hypertension or long-term risk, but the evidence-based value is low, giving no strong proof in terms of its relevance and continuity. This paper summarizes the existing evidence in the above points, puts forward its own insights, and looks forward to the future direction of scientific research, with a view to providing some references for future researcht.

Downloads

Download data is not yet available.

References

Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M, Maruhashi T, Tanaka A, Morikawa N, Nishimiya K, Akashi N, Tanaka Y, Otani N, Morita M, Miyata H, Takada T, Tsutani H, Ogino K, Ichida K, Hisatome I, Abe K. Exploring the multifaceted link between uric acid and health: a review of recent studies on multiple diseases. Biomolecules. 2023 Oct 13;13(10):1519.

Sun J, Yi S. The 2023 Chinese Guidelines for the Prevention and Treatment of Hypertension Updating Clinical Practice[J]. Cardiovascular and Circulation,2023,42(3):203-206,212.

Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, Borghi C, Piani F, Cara-Fuentes G, Bjornstad P, Lanaspa MA, Johnson RJ. Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020 Jul 18;33(7):583-594.

Zhang Chuanhai, Tao Guizhou. A comprehensive understanding of the etiology of hypertension[J]. Medicine and Philosophy,2012,33(14):65-67.

Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis JP, Campbell H, Theodoratou E. Serum uric acid levels and multiple health outcomes: an umbrella review of the evidence from observational studies, randomized controlled trials, and Mendelian randomization studies. British Medical Journal. 2017 Jun 7;357:J2376.

Li X, Meng X, He Y, Spiliopoulou A, Timofeeva M, Wei WQ, Gifford A, Yang T, Varley T, Tzoulaki I, Joshi P, Denny JC, Mckeigue P, Campbell H, Theodoratou E. Genetically determined serum urate levels and cardiovascular and other diseases in the UK Biobank cohort: A phenome-wide mendelian randomization study. PLoS Med. 2019 Oct 18;16(10):e1002937.

Gill D, Cameron AC, Burgess S, Li X, Doherty DJ, Karhunen V, Abdul-Rahim AH, Taylor-Rowan M, Zuber V, Tsao PS, Klarin D; VA Million Veteran Program. Evangelou E, Elliott P, Damrauer SM, Quinn TJ, Dehghan A, Theodoratou E, Dawson J, Tzoulaki I. Urate, Blood Pressure, and Cardiovascular Disease. Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials. Hypertension. 2021 Feb;77(2):383-392.

Yang Y, Zhang X, Jin Z, Zhao Q. Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta- analysis. J Thromb Thrombolysis. 2021 Nov;52(4):1084-1093.

Liu L, Zhang X, Li Q, Qie R, Han M, Zhan S, Zhang J, Zhang L, Zhang C, Hong F. Serum uric acid and risk of prehypertension: a dose-response meta-analysis of 17 observational studies of approximately 79 thousand participants. Acta Cardiol. 2022 Apr;77(2):136-145.

Zhao L, Cao L, Zhao TY, Yang X, Zhu XX, Zou HJ, Wan WG, Xue Y. Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis. Chin Med J (Engl). 2020 Apr 20;133(8):982-993.

Mackenzie IS, Hawkey CJ, Ford I, Greenlaw N, Pigazzani F, Rogers A, Struthers AD, Begg AG, Wei L, Avery AJ, Taggar JS, Walker A, Duce SL, Barr RJ. Dumbleton JS, Rooke ED, Townend JN, Ritchie LD, MacDonald TM; ALL-HEART Study Group. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomized, open-label, blinded-endpoint trial. Lancet. 2022 Oct 8;400(10359):1195-1205.

Li Xiangke, Li Shengshi, Zhang Xiaolin, et al. A 6-year follow-up study of serum uric acid levels and hypertension incidence in a community-based population[J]. Heart

Cerebrovascular Disease Control,2021,21(5):422-425. DOI:10.3969/j.issn.1009-816x.2021.05.002.Xie Rong,Niu Xiaona,Zhang Yannan,et al. Study on the correlation between uric acid and H-type hypertension[J]. Journal of China Medical University,2022,51(2):101-105.

Zhou Yini,Zhao Linxi,Wan Policy. Detection of hyperuricemia and correlation with hypertension in 116,553 cases of physical examination[J]. Health Research,2023,43(5):504-508.

Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment. and Renal Impairment. Int J Mol Sci. 2022 Mar 16;23(6):3188.

Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative Stress and Hypertension. Circ Res. 2021 Apr 2;128(7):993-1020 .

Ma J, Li Y, Yang X, Liu K, Zhang X, Zuo X, Ye R, Wang Z, Shi R, Meng Q, Chen X. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023 Apr 20;8(1):168.

Wang XD, Liu J, Zhang YC, Wang Y, Wang Y, Ma D. Correlation between the elevated uric acid levels and circulating renin-angiotensin-aldosterone system activation in patients with atrial fibrillation. Cardiovasc Diagn Ther. 2021 Feb;11(1):50-55.

Downloads

Published

24-07-2024

How to Cite

Wang, Y., & Li, Z. (2024). Uric Acid Plays a Key Role in Hypertension and its Long-term Risk. Highlights in Science, Engineering and Technology, 109, 186-192. https://doi.org/10.54097/9hcmxc60